PFO
MBOT icon

Pathstone Family Office’s Microbot Medical MBOT Stock Holding History

Pathstone Family Office’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25
Closed – – 1054
2020
Q4 		$0 Hold
25
– – ﹤0.01% 1255
2020
Q3 		$0 Hold
25
– – ﹤0.01% 913
2020
Q2 		$0 Hold
25
– – ﹤0.01% 869
2020
Q1 		$0 Buy
+25
New +$219 ﹤0.01% 801
2019
Q4 		– Sell
-25
Closed – – 552
2019
Q3 		$0 Hold
25
– – ﹤0.01% 678
2019
Q2 		$0 Hold
25
– – ﹤0.01% 788
2019
Q1 		$0 Hold
25
– – ﹤0.01% 928
2018
Q4 		$0 Hold
25
– – ﹤0.01% 549
2018
Q3 		$0 Buy
25
+20
+400% +$173 ﹤0.01% 249
2018
Q2 		$0 Sell
5
-20
-80% -$243 ﹤0.01% 256
2018
Q1 		$0 Buy
25
+20
+400% +$270 ﹤0.01% 378
2017
Q4 		$0 Sell
5
-20
-80% -$339 ﹤0.01% 185
2017
Q3 		$0 Buy
25
+5
+25% +$88 ﹤0.01% 272
2017
Q2 		$0 Sell
20
-5
-20% -$276 ﹤0.01% 540
2017
Q1 		$2K Buy
+25
New +$2.19K ﹤0.01% 396
2016
Q4 		– Sell
-25
Closed -$5K – 158
2016
Q3 		$5K Buy
+25
New +$3.26K 0.01% 165

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pathstone Family Office's MBOT Position: Q1 2021 in Review

Pathstone Family Office sold out of Microbot Medical (MBOT) in Q1 2021, closing a stake of 25 shares.

Pathstone Family Office first reported a position in MBOT in Q3 2016 and held it in 16 quarters. The position peaked at $5K in Q3 2016. 25 funds tracked by Wall St. Rank hold MBOT as of Q1 2021.

  • Pathstone Family Office reported no remaining Microbot Medical position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 25 Microbot Medical shares in Q1 2021.
  • Pathstone Family Office first reported a position in Microbot Medical in Q3 2016 and held it in 16 quarters.
  • Pathstone Family Office's Microbot Medical position peaked at $5K in Q3 2016.
  • 25 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.